Abstract BACKGROUND: Tranexamic acid (TXA) is a common antifibrinolytic agent used to minimize bleeding in cardiac surgery. Up to 50% cardiac surgical patients have chronic renal dysfunction (CRD). Optimal dosing..
Read MoreTags Archives: antifibrinolysis
- Home
- antifibrinolysis
Search
Collaborations: Luc Puis – TransplantNews – Dr. Oleksandr Babliak – Mohamed Gibreel – Prof. Elio Carvalho – Mohammed Zidan – Dr. Sam Zeraatian – Pierluigi Incarnato – The echo Lady – Sedat Gündöner – Prof. Daniel Tobler – Maria Ludmila Setti – Dr. Mario Finazzo – Mastersofultrasound – Jerry W. Jones – Omayyah Dar Odeh – Pediatricecho – Salman Butt
Recent Posts
- Guiding complexity in V-A ECMO weaning decisions for cardiogenic shock: Insights from a conjoint analysis
- Heparin Exposure Adjustment to Reduce Thrombo-hemorrhagic Complications After Venoarterial Extracorporeal Membrane Oxygenator Cannulation: The HEART-ECMO Observational Cohort Study
- Oxygenator-related gaseous microemboli and postoperative delirium after on-pump coronary artery bypass grafting: a prospective cohort study
- Clinical characterization of membrane oxygenator exhaust capnometry during venovenous extracorporeal membrane oxygenation
- Avoidance of Hyperoxemia Versus Routine Hyperoxia During Cardiopulmonary Bypass in Children With Cyanotic Congenital Heart Disease—A Systematic Review and Meta-Analysis
We use cookies to provide you with the best possible user experience. By continuing to use our site, you agree to their use. Learn more

